Literature DB >> 20549003

Host-virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem.

John Paul Pezacki1, Ragunath Singaravelu, Rodney K Lyn.   

Abstract

The hepatitis C virus (HCV) is a global health issue with no vaccine available and limited clinical treatment options. Like other obligate parasites, HCV requires host cellular components of an infected individual to propagate. These host-virus interactions during HCV infection are complex and dynamic and involve the hijacking of host cell environments, enzymes and pathways. Understanding this unique molecular biosystem has the potential to yield new and exciting strategies for therapeutic intervention. Advances in genomics and proteomics have opened up new possibilities for the rapid measurement of global changes at the transcriptional and translational levels during infection. However, these techniques only yield snapshots of host-virus interactions during HCV infection. Other new methods that involve the imaging of biomolecular interactions during HCV infection are required to identify key interactions that may be transient and dynamic. Herein we highlight systems biology based strategies that have helped to identify key host-virus interactions during HCV replication and infection. Novel biophysical tools are also highlighted for identification and visualization of activities and interactions between HCV and its host hepatocyte. As some of these methods mature, we expect them to pave the way forward for further exploration of this complex biosystem and elucidation of mechanisms for HCV pathogenesis and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549003     DOI: 10.1039/b924668c

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  13 in total

1.  Activity-based protein profiling identifies a host enzyme, carboxylesterase 1, which is differentially active during hepatitis C virus replication.

Authors:  David R Blais; Rodney K Lyn; Michael A Joyce; Yanouchka Rouleau; Rineke Steenbergen; Nicola Barsby; Lin-Fu Zhu; Adrian F Pegoraro; Albert Stolow; David L Tyrrell; John Paul Pezacki
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  MicroRNAs regulate the immunometabolic response to viral infection in the liver.

Authors:  Ragunath Singaravelu; Shifawn O'Hara; Daniel M Jones; Ran Chen; Nathan G Taylor; Prashanth Srinivasan; Curtis Quan; Dominic G Roy; Rineke H Steenbergen; Anil Kumar; Rodney K Lyn; Dennis Özcelik; Yanouchka Rouleau; My-Anh Nguyen; Katey J Rayner; Tom C Hobman; David Lorne Tyrrell; Rodney S Russell; John Paul Pezacki
Journal:  Nat Chem Biol       Date:  2015-10-19       Impact factor: 15.040

3.  Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.

Authors:  Deborah L Diamond; Alexei L Krasnoselsky; Kristin E Burnum; Matthew E Monroe; Bobbie-Jo Webb-Robertson; Jason E McDermott; Matthew M Yeh; Jose Felipe Golib Dzib; Nathan Susnow; Susan Strom; Sean C Proll; Sarah E Belisle; David E Purdy; Angela L Rasmussen; Kathie-Anne Walters; Jon M Jacobs; Marina A Gritsenko; David G Camp; Renuka Bhattacharya; James D Perkins; Robert L Carithers; Iris W Liou; Anne M Larson; Arndt Benecke; Katrina M Waters; Richard D Smith; Michael G Katze
Journal:  Hepatology       Date:  2012-04-24       Impact factor: 17.425

4.  Opportunities in proteomics to understand hepatitis C and HIV coinfection.

Authors:  Eric G Meissner; Anthony F Suffredini; Shyamasundaran Kottilil
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

5.  Fluorescence lifetime imaging of alterations to cellular metabolism by domain 2 of the hepatitis C virus core protein.

Authors:  Nirmal Mazumder; Rodney K Lyn; Ragunath Singaravelu; Andrew Ridsdale; Douglas J Moffatt; Chih-Wei Hu; Han-Ruei Tsai; John McLauchlan; Albert Stolow; Fu-Jen Kao; John Paul Pezacki
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

6.  Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA.

Authors:  Tomomi Ando; Hiromi Imamura; Ryosuke Suzuki; Hideki Aizaki; Toshiki Watanabe; Takaji Wakita; Tetsuro Suzuki
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

7.  Chemical proteomic identification of T-plastin as a novel host cell response factor in HCV infection.

Authors:  Young-Hwa Yoo; JiHyeon Yun; Chang No Yoon; Jun-Seok Lee
Journal:  Sci Rep       Date:  2015-04-24       Impact factor: 4.379

8.  Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication.

Authors:  Zheng Pei; Guoli Shi; Saki Kondo; Masahiko Ito; Aya Maekawa; Mariko Suzuki; Izumu Saito; Tetsuro Suzuki; Yumi Kanegae
Journal:  Sci Rep       Date:  2013-12-20       Impact factor: 4.379

9.  Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes.

Authors:  Rodney K Lyn; Ragunath Singaravelu; Stacia Kargman; Shifawn O'Hara; Helen Chan; Renata Oballa; Zheng Huang; Daniel M Jones; Andrew Ridsdale; Rodney S Russell; Anthony W Partridge; John Paul Pezacki
Journal:  Sci Rep       Date:  2014-04-01       Impact factor: 4.379

10.  Bidirectional lipid droplet velocities are controlled by differential binding strengths of HCV core DII protein.

Authors:  Rodney K Lyn; Graham Hope; Allison R Sherratt; John McLauchlan; John Paul Pezacki
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.